SYSTEMIC TREATMENT OF BLOOD-SUCKING PARASITES AND BLOOD CONSUMING PARASITES BY ORAL ADMINISTRATION OF ANTIPARASITIC Russian patent published in 2014 - IPC A61K31/44 A61P33/10 A61P33/14 

FIELD: medicine.

SUBSTANCE: declared group of inventions refers to veterinary science and aims at controlling blood-sucking parasites and consuming parasites. The composition contains an antiparasitic effective subtoxic amount of imidacloprid in a single dose making 0.25 mg/kg to 30 mg/kg for oral delivery. Imidacloprid is the only antiparasitic being an ingredient of the composition. What is declared is using the above composition. The subtoxic amount of imidacloprid in a single dose makes 0.25 mg/kg to 30 mg/kg. The infestation is eliminated within 1-72 hours after administration of the single dose.

EFFECT: declared group of inventions provides effective elimination of blood sucking parasites and blood consuming parasites.

24 cl, 6 tbl, 2 ex